Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor

被引：9
|
作者：
Robert, Lucie [1 ,2 ]
Langner-Lemercier, Sophie [3 ]
Angibaud, Alexis [1 ]
Sale, Alexandre [1 ]
Thepault, Fanny [4 ]
Corre, Romain [1 ,5 ]
Lena, Herve [1 ,5 ]
Ricordel, Charles [1 ,5 ]
机构：
[1] CHU Rennes, Resp Med Dept, Rennes, France
[2] CLCC Eugene Marquis, Serv Oncol Med, Rennes, France
[3] CHU Rennes, Neurol Dept, Rennes, France
[4] CH St Malo, Resp Med Dept, St Malo, France
[5] CLCC Eugene Marquis, Chem Oncogenesis Stress & Signaling, INSERM, U1242, Rennes, France
来源：
CLINICAL LUNG CANCER | 2020年 / 21卷 / 05期
关键词：
Atezolizumab; Immune encephalitis; Immune-related adverse events; NSCLC; Nivolumab; NEUROLOGICAL TOXICITIES; IPILIMUMAB; MELANOMA;
D O I：
10.1016/j.cllc.2020.03.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E474 / E477
页数：4
相关论文
共 50 条
  • [21] Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy
    Zhou, Nanruoyi
    Velez, Maria A.
    Owen, Dwight
    Lisberg, Aaron E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (09): : 1287 - 1290
  • [22] Checkpoint Inhibitor Immune-Related Adverse Events: A Multimodality Pictorial Review
    Capaccione, Kathleen M.
    Valiplackal, Jacienta P.
    Huang, Alice
    Roa, Tina
    Fruauff, Alana
    Liou, Connie
    Kim, Eleanor
    Khurana, Sakshi
    Maher, Mary
    Ma, Hong
    Ngyuen, Pamela
    Mak, Serena
    Dumeer, Shifali
    Lala, Sonali
    D'souza, Belinda
    Laifer-Narin, Sherelle
    Desperito, Elise
    Ruzal-Shapiro, Carrie
    Salvatore, Mary M.
    ACADEMIC RADIOLOGY, 2022, 29 (12) : 1869 - 1884
  • [23] Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
    Reschke, Robin
    Gussek, Philipp
    Boldt, Andreas
    Sack, Ulrich
    Koehl, Ulrike
    Lordick, Florian
    Gora, Thomas
    Kreuz, Markus
    Reiche, Kristin
    Simon, Jan-Christoph
    Ziemer, Mirjana
    Kunz, Manfred
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [24] Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Middha, Pooja
    Thummalapalli, Rohit
    Quandt, Zoe
    Balaratnam, Karmugi
    Cardenas, Eduardo
    Falcon, Christina J.
    Margaret Lung Group, Princess
    Gubens, Matthew A.
    Huntsman, Scott
    Khan, Khaleeq
    Li, Min
    Lovly, Christine M.
    Patel, Devalben
    Zhan, Luna Jia
    Liu, Geoffrey
    Aldrich, Melinda C.
    Schoenfeld, Adam
    Ziv, Elad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [25] Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience
    Bhatlapenumarthi, Vineel
    Patwari, Anannya
    Harb, Antoine J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2789 - 2800
  • [26] Immune-related Neutropenia Following Treatment With Immune Checkpoint Inhibitors
    Finkel, Inbar
    Sternschuss, Michal
    Wollner, Mira
    Shamai, Sivan
    Peled, Nir
    Turgeman, Ilit
    Shochat, Tzippy
    Dudnik, Elizabeth
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (02) : 67 - 74
  • [27] Association between immune-related adverse events and prognosis in patients treated with immune checkpoint inhibitors in melanoma: A surrogacy analysis
    Euvrard, Romain
    Robert, Marie
    Mainbourg, Sabine
    Dalle, Stephane
    Lega, Jean-Christophe
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (02) : 369 - 379
  • [28] A network meta-analysis of the risk of immune-related renal toxicity in cancer patients treated with immune checkpoint inhibitors
    Abdel-Rahman, Omar
    Fouad, Mona
    IMMUNOTHERAPY, 2016, 8 (05) : 665 - 674
  • [29] Immune-Related Thyroiditis with Immune Checkpoint Inhibitors
    Iyer, Priyanka C.
    Cabanillas, Maria E.
    Waguespack, Steven G.
    Hu, Mimi I.
    Thosani, Sonali
    Lavis, Victor R.
    Busaidy, Naifa L.
    Subudhi, Sumit K.
    Diab, Adi
    Dadu, Ramona
    THYROID, 2018, 28 (10) : 1243 - 1251
  • [30] Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy
    Das, Satya
    Ciombor, Kristen K.
    Haraldsdottir, Sigurdis
    Pumpalova, Yoanna
    Sahin, Ibrahim H.
    Pineda, G.
    Shyr, Yu
    Lin, E. P.
    Hsu, Chih-Yuan
    Chu, Shih-Kai
    Goff, Laura W.
    Cardin, Dana B.
    Bilen, Mehmet A.
    Fisher, George A.
    Wu, Christina
    Berlin, Jordan
    ONCOLOGIST, 2020, 25 (08) : 669 - 679
12345